Factors associated to risk of relapse in schizophrenia: 36 month results from the schizophrenia outpatients health outcomes (SOHO) study

被引：0
|
作者：
Novick, D
Haro, JM
Suarez, D
Ratcliffe, M
机构：
[1] Eli Lilly & Co, Windlesham GU20 6PH, Surrey, England
[2] San Joan Deu SSM, Res & Dev Unit, Barcelona, Spain
来源：
SCHIZOPHRENIA RESEARCH | 2006年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：60 / 60
页数：1
相关论文
共 50 条
  • [41] Antipsychotic treatment discontinuation in the outpatient treatment for schizophrenia: 24-month results from the Pan-European SOHO (schizophrenia outpatient health outcomes) study
    Novick, D
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 71S - 71S
  • [42] Tolerability of outpatient antipsychotic treatment: 6-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Lambert, K
    Jones, P
    Novick, D
    Lorenzo, M
    Tzivelekis, S
    Ratcliffe, M
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 188 - 188
  • [43] Antipsychotic treatment discontinuation in the outpatient treatment for schizophrenia: 24-month results from the pan-European SOHO (schizophrenia outpatient health outcomes) study
    Haro, J
    Novick, D
    Belger, M
    Tzivelekis, S
    Murray, D
    Texeira, JM
    Alonso, J
    Bousono, MG
    Gasquet, I
    Kristensen, H
    Jones, PB
    Croudace, T
    Knapp, M
    Lepine, JP
    Mavreas, V
    Naber, D
    Pancheri, P
    Slooff, CJ
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 486 - 486
  • [44] Baseline results from the Schizophrenia Outpatient Health Outcomes study (SOHO): A 3-year, pan-European, observational health outcomes study in schizophrenia
    Haro, JM
    Edgell, ET
    Frewer, P
    Novick, D
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 265 - 265
  • [45] Atypical antipsychotic treatment patterns: Results from the Schizophrenia Outpatient Health Outcomes (SOHO) study
    Edgell, ET
    Frewer, P
    Haro, JM
    Perahia, D
    Wright, P
    JOURNAL OF PSYCHOPHARMACOLOGY, 2002, 16 (03) : A19 - A19
  • [46] 36-month cost-utility analysis of antipsychotic treatments in patients with schizophrenia in the pan-European soho (schizophrenia outpatient health outcomes) study
    Windmeijer, F.
    Brown, J.
    Novick, D.
    Hong, J.
    Knapp, M.
    Kontodimas, S.
    Ratcliffe, M.
    VALUE IN HEALTH, 2007, 10 (03) : A78 - A79
  • [47] Antipsychotic treatment discontinuation in the outpatient treatment for schizophrenia. 24-month results from the Pan-European SOHO (Schizophrenia Outpatient Health Outcomes) study
    Haro, JM
    Novick, D
    Belger, M
    Tzivelekis, S
    Bushe, C
    Murray, D
    Texeira, JM
    JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (05) : A10 - A10
  • [48] Olanzapine, risperidone or quetiapine treatment initiation: 12-month schizophrenia outpatient health outcomes (SOHO) study results
    Novick, D
    Haro, JM
    Belger, M
    Tzivelekis, S
    Alonso, J
    Gasquet, I
    Kristensen, H
    Jones, PB
    Knapp, M
    Lepine, JP
    Mavreas, V
    Murray, D
    Naber, D
    Pancheri, P
    Slooff, CJ
    Teixeira, JM
    EUROPEAN PSYCHIATRY, 2004, 19 : 172S - 173S
  • [49] Predictors of antipsychotic treatment continuation in the outpatient setting: 12-month results from the Schizophrenia Outpatient Health Outcomes (SOHO) study
    Haro, JM
    Novick, D
    Belger, M
    Tzivelekis, S
    Ratcliffe, M
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S233 - S234
  • [50] The European Schizophrenia Outpatient Health Outcomes Study: Effectiveness results of the French cohort of schizophrenic outpatients over a 36-month follow-up
    Gasquet, I.
    Chartier, F.
    Tcherny-Lessenot, S.
    Lepine, J. -P
    REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 2009, 57 (01): : 25 - 32
12345